Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal CancerArlene A. Forastiere, Helmuth Goepfert, Moshe Maor, Thomas F. Pajak, Randal S. Weber, William H. Morrison, Bonnie S. Glisson, Andy Trotti, John A. Ridge, C. Chao, Glen Peters, Ding-Jen Lee, Andrea Leaf, John F. Ensley, Jay S. Cooper
New England Journal of Medicine. 20033,178 CitationsOPEN ACCESS
Efficacy of Larotrectinib in <i>TRK</i> Fusion–Positive Cancers in Adults and ChildrenAlexander Drilon, Theodore W. Laetsch, Shivaani Kummar, Steven G. DuBois, Ulrik Lassen, George D. Demetri, Michael J. Nathenson, Robert C. Doebele, Anna F. Farago, Alberto S. Pappo, Brian Turpin, Afshin Dowlati, Marcia S. Brose, Leo Mascarenhas, Noah Federman, Jordan Berlin, Wafik S. El‐Deiry, Christina S. Baik, John F. Deeken, Valentina Boni, Ramamoorthy Nagasubramanian, Matthew H. Taylor, Erin R. Rudzinski, Funda Meric‐Bernstam, Davendra Sohal, C. Patrick, Luis E. Raez, Jaclyn F. Hechtman, Ryma Benayed, Marc Ladanyi, Brian B. Tuch, Kevin Ebata, Scott Cruickshank, Nora Ku, Michael C. Cox, Douglas S. Hawkins, David S. Hong, David M. Hyman
New England Journal of Medicine. 20182,775 CitationsOPEN ACCESS
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid CancerMartin Schlumberger, Makoto Tahara, Lori J. Wirth, Bruce Robinson, Marcia S. Brose, Rossella Elisei, Mouhammed Amir Habra, Kate Newbold, Manisha H. Shah, Ana O. Hoff, Andrew G. Gianoukakis, Naomi Kiyota, Matthew H. Taylor, Sung‐Bae Kim, Monika K. Krzyzanowska, Corina E. Dutcus, Begoña de las Heras, Junming Zhu, Steven I. Sherman
New England Journal of Medicine. 20152,094 CitationsOPEN ACCESS
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx CancerArlene A. Forastiere, Qiang Zhang, Randal S. Weber, Moshe Maor, Helmuth Goepfert, Thomas F. Pajak, William H. Morrison, Bonnie S. Glisson, Andy Trotti, John A. Ridge, Wade L. Thorstad, Henry Wagner, John F. Ensley, Jay S. Cooper
Journal of Clinical Oncology. 20121,290 CitationsOPEN ACCESS
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomasAdam J. Bass, Hideo Watanabe, Craig H. Mermel, Soyoung Yu, Sven Perner, Roel G.W. Verhaak, So Young Kim, Leslie Wardwell, Pablo Tamayo, Irit Gat‐Viks, Alex H. Ramos, Michele Sue‐Ann Woo, Barbara A. Weir, Gad Getz, Rameen Beroukhim, Michael O'Kelly, Amit Dutt, Orit Rozenblatt–Rosen, Piotr Dziunycz, Justin Komisarof, Lucian R. Chirieac, Christopher J. Lafargue, Veit Scheble, Theresia Wilbertz, Changqing Ma, Shilpa Rao, Hiroshi Nakagawa, Douglas B. Stairs, Lin Lin, Thomas J. Giordano, Patrick Wagner, John D. Minna, Adi F. Gazdar, Chang‐Qi Zhu, Marcia S. Brose, Ivan Cecconello, Ulysses Ribeiro, Suely Kazue Nagahashi Marie, Olav Dahl, Ramesh A. Shivdasani, Ming‐Sound Tsao, Mark A. Rubin, Kwok‐Kin Wong, Aviv Regev, William C. Hahn, David G. Beer, Anil K. Rustgi, Matthew Meyerson
Nature Genetics. 2009956 CitationsOPEN ACCESS